MRK.DE Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 17:35):

Stats
Dagens volum	282 863
Gjennomsnittsvolum	283 426
Markedsverdi	64.94B
EPS	€0 ( 2024-03-06 )
Neste inntjeningsdato	( €1.980 ) 2024-05-15
Last Dividend	€2.20 ( 2023-05-02 )
Next Dividend	€0 ( N/A )
P/E	23.42
ATR14	€0.0640 (0.04%)

Volum Korrelasjon

Lang: 0.00 (neutral)

Kort: -0.09 (neutral)

Signal:(53.777) Neutral

Merck KGaA Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Merck KGaA Korrelasjon - Valuta/Råvare

0.85
( strong )

0.87
( strong )

-0.72
( moderate negative )

0.87
( strong )

0.18
( neutral )

0.72
( moderate )

Merck KGaA Økonomi

Annual	2023
Omsetning:	€20.99B
Bruttogevinst:	€11.67B (55.59 %)
EPS:	€6.50

FY	2023
Omsetning:	€20.99B
Bruttogevinst:	€11.67B (55.59 %)
EPS:	€6.50

FY	2022
Omsetning:	€22.23B
Bruttogevinst:	€13.71B (61.65 %)
EPS:	€7.65

FY	2021
Omsetning:	€19.69B
Bruttogevinst:	€12.34B (62.66 %)
EPS:	€7.03

Financial Reports:

No articles found.

Merck KGaA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€2.20 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Merck KGaA Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.41 - Stable (8.28%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.418	2000-05-12
Last Dividend	€2.20	2023-05-02
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	25	--
Total Paid Out	€22.03	--
Avg. Dividend % Per Year	0.00%	--
Score	3.43	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.41
Div. Directional Score	8.93	--

Next Divdend (Est)
(2025-03-31)

€2.36 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
PRU.DE	Ex Dividend Knight	2023-09-07	Annually	0.00%
BEZ.DE	Ex Dividend Junior	2023-05-11	Annually	0.00%
IBM.DE	Ex Dividend Knight	2023-08-09	Quarterly	0.00%
SNW.DE	Ex Dividend Knight	2023-05-30	Annually	0.00%
CPIA.F	No Dividend Player	2023-06-29	Annually	0.00%
LHOG.F	Ex Dividend Junior	2023-08-24	Semi-Annually	0.00%
185.DE	Ex Dividend Junior	2023-08-07	Quarterly	0.00%
UTDI.DE	Ex Dividend Junior	2023-05-18	Annually	0.00%
ED4.DE	Ex Dividend Junior	2023-06-29	Sporadic	0.00%
NOA3.DE	Ex Dividend Knight	2023-10-23	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.135	1.500	7.31	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0575	1.200	8.08	9.70	[0 - 0.3]
returnOnEquityTTM	0.105	1.500	9.95	10.00	[0.1 - 1]
payoutRatioTTM	0.440	-1.000	5.60	-5.60	[0 - 1]
currentRatioTTM	1.425	0.800	7.88	6.30	[1 - 3]
quickRatioTTM	0.822	0.800	9.87	7.90	[0.8 - 2.5]
cashRatioTTM	0.228	1.500	9.85	10.00	[0.2 - 2]
debtRatioTTM	0.194	-1.500	6.76	-10.00	[0 - 0.6]
interestCoverageTTM	11.33	1.000	6.92	6.92	[3 - 30]
operatingCashFlowPerShareTTM	8.70	2.00	7.10	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.52	2.00	7.74	10.00	[0 - 20]
debtEquityRatioTTM	0.358	-1.500	8.57	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.590	1.000	3.50	3.50	[0.2 - 0.8]
operatingProfitMarginTTM	0.182	1.000	8.36	8.36	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.396	1.000	8.91	8.91	[0.2 - 2]
assetTurnoverTTM	0.427	0.800	-0.484	-0.387	[0.5 - 2]
Total Score				12.44

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	23.35	1.000	7.74	0	[1 - 100]
returnOnEquityTTM	0.105	2.50	9.97	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.52	2.00	8.49	10.00	[0 - 30]
dividendYielPercentageTTM	1.450	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.70	2.00	7.10	10.00	[0 - 30]
payoutRatioTTM	0.440	1.500	5.60	-5.60	[0 - 1]
pegRatioTTM	-9.98	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.180	1.000	7.99	0	[0.1 - 0.5]
Total Score				5.41

Merck KGaA

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.